Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Squamous Carcinoma Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT04548440
What this trial is testing

Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-Sen University Cancer Center 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047
What this trial is testing

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Who this might be right for
Lung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more
UNICANCER 646
Testing effectiveness (Phase 2)Looking for participantsNCT06747585
What this trial is testing

Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

Who this might be right for
Squamous Non-small-cell Lung CancerHead and Neck Squamous Cell CarcinomaCervical Squamous Cell Carcinoma+1 more
Alentis Therapeutics AG 170
Not applicableLooking for participantsNCT05028725
What this trial is testing

Novel Strategy for Early Detection of Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal Squamous Dysplasia
University of California, San Francisco 289
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07046221
What this trial is testing

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

Who this might be right for
Esophagus Cancer
Fujian Cancer Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT03278626
What this trial is testing

Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
NYU Langone Health 12
Testing effectiveness (Phase 2)UnknownNCT03732508
What this trial is testing

SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer

Who this might be right for
Advanced Esophageal Squamous Cell Cancer
Jiangsu HengRui Medicine Co., Ltd. 30
Testing effectiveness (Phase 2)Looking for participantsNCT07290010
What this trial is testing

The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Hebei Medical University Fourth Hospital 25
Not applicableStudy completedNCT01981876
What this trial is testing

Study of Esophageal Squamous Dysplasia Prevalence at Tenwek Hospital

Who this might be right for
Esophageal Dysplasia
Tenwek Hospital 305
Testing effectiveness (Phase 2)UnknownNCT04215471
What this trial is testing

NeoAdjuvant Therapy With Immunoreagent (SHR-1316) for Resectable Oesophageal Squamous Cell carciNoma

Who this might be right for
Oesophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)UnknownNCT06186609
What this trial is testing

PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Affiliated Hospital of Nantong University 68
Testing effectiveness (Phase 2)UnknownNCT03486509
What this trial is testing

Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma
Fujian Cancer Hospital 2
Large-scale testing (Phase 3)Not Yet RecruitingNCT06914011
What this trial is testing

Circulating Tumor DNA MRD-Guided Adjuvant Therapy for Curatively Resected Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Asan Medical Center 172
Testing effectiveness (Phase 2)UnknownNCT05828381
What this trial is testing

Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer

Who this might be right for
Immunotherapy;Envafolimab; Esophageal Cancer
Fujian Medical University Union Hospital 33
Early research (Phase 1)Ended earlyNCT04272034
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more
Incyte Corporation 105
Testing effectiveness (Phase 2)Active Not RecruitingNCT07711470
What this trial is testing

Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 140
Not applicableNot Yet RecruitingNCT07573397
What this trial is testing

A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Fudan University 88
Early research (Phase 1)UnknownNCT03634982
What this trial is testing

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

Who this might be right for
Solid Tumors
Revolution Medicines, Inc. 133
Testing effectiveness (Phase 2)Active Not RecruitingNCT05094336
What this trial is testing

Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

Who this might be right for
Advanced MTAP-null Solid Tumors
Amgen 329
Next Page